Completed
Evaluating the Safety and Tolerability of Ruxolitinib in Antiretroviral-Treated HIV-Infected Adults
NCT02475655
- Conditions
- Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
- Locations
-
- Alabama CRS Birmingham, Alabama, United States
- UCLA CARE Center CRS Los Angeles, California, United States
- UCSD Antiviral Research Center CRS San Diego, California, United States
- Ucsf Hiv/Aids Crs San Francisco, California, United States